What does EMD Serono stand for?
EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, is a specialized biopharmaceutical company dedicated to developing therapies with groundbreaking potential. We are known in the United States as EMD, a name that stands for Emmanuel Merck, Darmstadt, heralding back to our roots in Germany.
What drugs does EMD Serono make?
Drugs Associated with EMD Serono, Inc.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
| Mavenclad Generic name: cladribine Drug class: antimetabolites | ||
| Ovidrel Generic name: chorionic gonadotropin (hcg) Drug class: gonadotropins | 1 review | 10 / 10 |
| Rebif Generic name: interferon beta-1a Drug class: interferons | 26 reviews | 7.0 / 10 |
Is EMD Serono part of Merck?
EMD Serono is the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the United States and Canada.
What is MS lifeline?
MS LifeLines is an educational patient support service sponsored by EMD Serono that supports patients throughout their MAVENCLAD journey. They offer one-on-one support, including basic MS educational resources and information to help you understand and stay on track with your MAVENCLAD treatment.
Is Merck and Merck Serono the same?
In the U.S. and Canada, Merck Serono is known as EMD Serono, as the former Merck subsidiary Merck & Co. holds the rights to the name Merck in those countries.
Who bought Serono?
Merck KGaA
Merck KGaA To Acquire Serono International S.A. For $13.3 Billion.
What is the difference between Merck and Merck Serono?
Merck KGaA and Serono operated as distinct entities until at least January 2007. In the U.S. and Canada, Merck Serono is known as EMD Serono, as the former Merck subsidiary Merck & Co. holds the rights to the name Merck in those countries.
How many employees EMD Serono?
Our 1,300 employees in the U.S. act boldly, empowered by cutting-edge science that delivers valuable medicines, drug-delivery devices and support services for patients with difficult-to-treat diseases.
When did Merck buy EMD Serono?
2006
In another few years, it would be shopping around for a buyer in what turned out to be a long and frustrating exercise, but the quest finally ended with the $13.3 billion purchase of Serono by E. Merck in 2006.
Is Mavenclad a cure for MS?
No, Mavenclad isn’t a cure for MS. It’s a disease-modifying treatment, which means that it can slow down the progression (worsening) of MS.
Who owns EMD Serono?
SeronoEMD Serono Inc. / Parent organization